Literature DB >> 16952550

Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair.

Raymond J Playford1, Angelica Belo, Richard Poulsom, Anthony J Fitzgerald, Kevin Harris, Isabella Pawluczyk, Joel Ryon, Thameen Darby, Marit Nilsen-Hamilton, Subrata Ghosh, Tania Marchbank.   

Abstract

BACKGROUND & AIMS: The lipocalin superfamily, including the mouse and human homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin, show great functional diversity including roles in olfaction, transportation, and prostaglandin synthesis in mammals. Their potential role in maintaining gastrointestinal mucosal integrity and repair is, however, unclear.
METHODS: Changes in 24p3/lcn2 expression in the mouse gut in response to various noxious agents were examined using Northern blot, in situ hybridization, and immunohistochemistry. Effects of recombinant 24p3/lcn2 on proliferation ([3H]-thymidine uptake), and restitution (cell-wounding migration) were assessed using human colonic HT29 and HCT116 cells. In addition, the effects of recombinant 24p3/lcn2 on the amount of gastric damage were assessed in rats treated with indomethacin (20 mg/kg) and restraint.
RESULTS: Marked up-regulation of expression of 24p3/lcn2 was seen throughout the gut in response to indomethacin or dextran sodium sulfate treatment. Expression was increased particularly in the surface epithelial cells and infiltrating inflammatory cells. Proliferation and restitution assays in the presence of recombinant wild-type sequence neutrophil gelatinase-associated lipocalin, wild-type cys(98)-24p3/lcn2, and mutant ala98-24p3/lcn2 showed that all 3 peptides caused a 3- to 4-fold increase in promigratory activity (P < .01 vs control) but did not influence proliferation. The administration of wild-type cys98-, or mutant ala98-24p3/lcn2 (25 and 50 microg/kg/h, respectively), given via the subcutaneous route, both caused similar reductions in the rat gastric damage model (60% reduction at highest dose, P < .01 vs control), although oral administration was ineffective.
CONCLUSIONS: 24p3/lcn2 facilitates mucosal regeneration by promoting cell migration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952550     DOI: 10.1053/j.gastro.2006.05.051

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

Review 1.  NGAL-Siderocalin in kidney disease.

Authors:  Neal Paragas; Andong Qiu; Maria Hollmen; Thomas L Nickolas; Prasad Devarajan; Jonathan Barasch
Journal:  Biochim Biophys Acta       Date:  2012-06-19

2.  Tumor Necrosis Factor α-Dependent Neutrophil Priming Prevents Intestinal Ischemia/Reperfusion-Induced Bacterial Translocation.

Authors:  Yen-Zhen Lu; Ching-Ying Huang; Yi-Cheng Huang; Tsung-Chun Lee; Wei-Ting Kuo; Yu-Chen Pai; Linda Chia-Hui Yu
Journal:  Dig Dis Sci       Date:  2017-01-31       Impact factor: 3.199

3.  Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.

Authors:  Zhimin Tong; Ajaikumar B Kunnumakkara; Huamin Wang; Yoichi Matsuo; Parmeswaran Diagaradjane; Kuzhuvelil B Harikumar; Vijaya Ramachandran; Bokyung Sung; Arup Chakraborty; Robert S Bresalier; Craig Logsdon; Bharat B Aggarwal; Sunil Krishnan; Sushovan Guha
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

4.  Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth.

Authors:  N Huang; D Bethell; C Card; J Cornish; T Marchbank; D Wyatt; K Mabery; R Playford
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-09-19       Impact factor: 2.416

5.  Ectopic Expression of Innate Immune Protein, Lipocalin-2, in Lactococcus lactis Protects Against Gut and Environmental Stressors.

Authors:  Piu Saha; Benoit Chassaing; Beng San Yeoh; Emilie Viennois; Xia Xiao; Mary J Kennett; Vishal Singh; Matam Vijay-Kumar
Journal:  Inflamm Bowel Dis       Date:  2017-07       Impact factor: 5.325

6.  Role of reactive nitrogen species generated via inducible nitric oxide synthase in vesicant-induced lung injury, inflammation and altered lung functioning.

Authors:  Vasanthi R Sunil; Jianliang Shen; Kinal Patel-Vayas; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-03-14       Impact factor: 4.219

7.  Prevention of trauma/hemorrhagic shock-induced lung apoptosis by IL-6-mediated activation of Stat3.

Authors:  Ana Moran; Anna I Tsimelzon; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; Susan G Hilsenbeck; Valeria Poli; David J Tweardy
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

8.  Lipocalin-2 Is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration.

Authors:  Shinrye Lee; Jong-Heon Kim; Jae-Hong Kim; Jung-Wan Seo; Hyung-Soo Han; Won-Ha Lee; Kiyoshi Mori; Kazuwa Nakao; Jonathan Barasch; Kyoungho Suk
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

9.  Urinary NGAL marks cystic disease in HIV-associated nephropathy.

Authors:  Neal Paragas; Thomas L Nickolas; Christina Wyatt; Catherine S Forster; Meghan Sise; Susan Morgello; Bernd Jagla; Charles Buchen; Peter Stella; Simone Sanna-Cherchi; Maria Luisa Carnevali; Silvia Mattei; Achiropita Bovino; Lucia Argentiero; Andrea Magnano; Prasad Devarajan; Kai M Schmidt-Ott; Landino Allegri; Paul Klotman; Vivette D'Agati; Ali G Gharavi; Jonathan Barasch
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

10.  Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine.

Authors:  Manuela Raffatellu; Michael D George; Yuko Akiyama; Michael J Hornsby; Sean-Paul Nuccio; Tatiane A Paixao; Brian P Butler; Hiutung Chu; Renato L Santos; Thorsten Berger; Tak W Mak; Renée M Tsolis; Charles L Bevins; Jay V Solnick; Satya Dandekar; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2009-05-08       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.